[Comparative efficacy of voltaren and naproxen in rheumatoid arthritis (double-blind trial)].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7027509)

Published in Ter Arkh on January 01, 1981

Authors

E S Tsvetkova, Ia A Sigidin

Articles by these authors

[Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis]. Patol Fiziol Eksp Ter (1991) 0.84

[Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis]. Ter Arkh (2008) 0.78

[New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines]. Ter Arkh (1998) 0.78

[State-of-the-art biological therapy of rheumatoid arthritis]. Vestn Ross Akad Med Nauk (2008) 0.77

[Cartilage-protective preparations in the therapy of osteoarthrosis]. Ter Arkh (1992) 0.75

[Effectiveness of intra-articular dimexide in combination with hydrocortisone and hydrocortisone in patients with juvenile rheumatoid arthritis]. Klin Med (Mosk) (1989) 0.75

[Effect of anti-inflammatory preparations on the process of thermogenesis in blood erythrocytes]. Biull Eksp Biol Med (1975) 0.75

[Clinical variants and results of therapy of toxico-allergic myocarditis]. Klin Med (Mosk) (1972) 0.75

[Combination of pseudohypoparathyroidism and osteomalacia]. Ter Arkh (1982) 0.75

[Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]. Ter Arkh (1985) 0.75

[Current anti-rheumatism agents]. Med Sestra (1978) 0.75

[Comparative effectiveness of voltaren and indomethacin in rheumatoid arthritis (according to the data of a double-blind study)]. Ter Arkh (1978) 0.75

[Some regularities in the onset rheumatic heart defects]. Ter Arkh (1971) 0.75

[A study of lymphocytes sensitized to heart tissue in patients with rheumatism]. Vopr Revm (1969) 0.75

[Hemopathies and collagenoses. V. Possible pathogenetic relations of collagenosis and leukemia]. Probl Gematol Pereliv Krovi (1968) 0.75

[Psychogenic pseudorheumatic carditis]. Sov Med (1976) 0.75

[The anti-inflammatory drug diclofenac]. Ter Arkh (1989) 0.75

[Non-steroidal anti-inflammatory therapy in rheumatology]. Ter Arkh (1986) 0.75

[Use of immunodepressive cytostatic agents in rheumatology]. Sov Med (1971) 0.75

[Institute of Rheumatology and progress of antirheumatic therapy]. Vestn Ross Akad Med Nauk (1998) 0.75

[Use of monoclonal antibodies to tumor necrosis factor (remicade) in rheumatoid arthritis: preliminary results]. Ter Arkh (2003) 0.75

[Unified criteria for assessing the efficacy of treatment of rheumatism]. Ter Arkh (1969) 0.75

[Comparative study of the cytogenetic activity of acetylsalicylic acid and brufen]. Vopr Revm (1981) 0.75

[Laser therapy of rheumatoid arthritis (clinico-morphological study)]. Ter Arkh (1983) 0.75

[The basic therapy of rheumatoid arthritis at an early stage]. Ter Arkh (1996) 0.75

[Gold preparations in therapy of rheumatoid and psoriatic arthritis]. Ter Arkh (2003) 0.75

[A trial of the use of the preparation Arthrotec for treating rheumatic diseases]. Ter Arkh (1995) 0.75

[Experience with using a new antirheumatic drug flugalin]. Ter Arkh (1985) 0.75

[Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)]. Ter Arkh (1985) 0.75

[Comparative evaluation of the effectiveness of intra-articular administration of orgotein and hydrocortisone in rheumatoid arthritis]. Ter Arkh (1988) 0.75

[A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis]. Ter Arkh (1987) 0.75

[Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)]. Ter Arkh (2001) 0.75

[Clinical experience with infliximab administration in patients with rheumatoid arthritis (according to Russian register data)]. Ter Arkh (2009) 0.75

[Criteria for comparative assessment of the efficacy of basic antirheumatic agents]. Vopr Revm (1970) 0.75

[Clinico-cybernetic criteria of manifestation of infectious-allergic myocarditis]. Klin Med (Mosk) (1974) 0.75

[New approaches to local antirheumatic therapy]. Ter Arkh (1990) 0.75

[Therapeutic effect and action mechanism of indomethacin in rheumatism]. Ter Arkh (1972) 0.75

[Voltaren in the treatment of rheumatic diseases]. Ter Arkh (1977) 0.75

[Current principles of anti-inflammatory therapy in rheumatology]. Ter Arkh (1978) 0.75

[Use of modified Stanford Health Assessment Questionnaire in patients with rheumatoid arthritis]. Revmatologiia (Mosk) (1990) 0.75

[Cytogenetic effects of chloroquine in a culture of human lymphocytes]. Biull Eksp Biol Med (1976) 0.75

[Use of levamisol in rheumatic diseases]. Ter Arkh (1977) 0.75

[Mechanism of action of antirheumatic preparations (effect of antirheumatic drugs on the level of nicotinamide adeninedinucleotide in blood)]. Vopr Revm (1970) 0.75

[Current therapy of rheumatoid arthritis]. Klin Med (Mosk) (1983) 0.75

[Mechanism of the therapeutic effect of dimethyl sulfoxide in rheumatoid arthritis]. Ter Arkh (1989) 0.75

[Hyperlipoproteinemic arthritis]. Ter Arkh (1987) 0.75

[New drugs in the therapy of rheumatoid arthritis]. Sov Med (1981) 0.75

[On the mechanism of the therapeutic action of antirheumatic preparations]. Ter Arkh (1967) 0.75

[Treatment of ochronosis with large doses of ascorbic acid]. Ter Arkh (1984) 0.75

[Severity of rheumocarditis and the effectiveness of drug treatment]. Vrach Delo (1975) 0.75

[Pachydermoperiostosis. A description of 2 cases]. Ter Arkh (1984) 0.75

[Certain disputable rheumatological problems]. Sov Med (1973) 0.75

[Use of glucose-6-phosphate dehydrogenase and transketolase for characterization of pathologic processes in the myocardium in rheumatism]. Kardiologiia (1976) 0.75

[Collagenoses and hemopathies. IV. Cytological aspects of allergy in collagenoses]. Vestn Akad Med Nauk SSSR (1968) 0.75

[Comparative effectiveness of new antirheumatic drugs]. Ter Arkh (1980) 0.75

[Piroxicam in the treatment of rheumatoid arthritis]. Ter Arkh (1988) 0.75

[Achievements of modern antirheumatism therapy]. Klin Med (Mosk) (1982) 0.75

[Controlled (double blind) study of various regimens of levamisole administration in rheumatoid arthritis]. Ter Arkh (1983) 0.75

[Administration of monoclonal antibodies to B-lymphocytes (rituximab) in rheumatoid arthritis in Russia]. Ter Arkh (2008) 0.75

[A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report)]. Ter Arkh (1993) 0.75

[Peculiarities of allergy in rheumatism]. Klin Med (Mosk) (1966) 0.75

[Heparin treatment of rheumatoid arthritis (apropos of I. A. Kartashov's article, "Heparin in the Overall Treatment of Rheumatoid Arthritis", Sov. Med., 1977, No. 10, pp. 72--75)]. Sov Med (1979) 0.75

[Certain errors in the conception of the pathogenesis of rheumatism. (On the article by A.M. Monaenkova "New theoretical aspects of the study of the pathogenesis of rheumocarditis", "Voprosy Revmatizma" 1974, no. 1, p.3)]. Vopr Revm (1976) 0.75

[Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis]. Ter Arkh (1987) 0.75

[Interaction of antirheumatic preparations with proteolytic enzymes]. Vopr Med Khim (1974) 0.75

[Mechanisms of the therapeutic effect of antirheumatic preparations]. Vopr Revm (1971) 0.75

[Combined forms of collagenoses]. Vutr Boles (1973) 0.75

[Corticosteroid therapy in modern medicine (on the 25th anniversary of the first application of cortisone)]. Sov Med (1974) 0.75

[Objective methods of testing new medical preparations]. Ter Arkh (1977) 0.75

[New principle of the treatment of rheumatoid arthritis: combined basic therapy]. Klin Med (Mosk) (1990) 0.75

[Multicenter study of the efficacy of dimethyl sulfoxide in rheumatoid arthritis and osteoarthritis deformans]. Ter Arkh (1987) 0.75

[Study of blood acid phosphatase levels in patients with rheumatism (several perspectives in the clinical study of lysosomal permeability)]. Ter Arkh (1969) 0.75

[Cytogenetic study of patients with rheumatism in the process of aspirin therapy]. Ter Arkh (1972) 0.75

[Clinico-roentgenological and scintigraphic parallels in aseptic femur head necrosis in patients with rheumatoid arthritis]. Ter Arkh (1987) 0.75

[Interaction of antirheumatic agents with proteolytic enzymes]. Vopr Med Khim (1973) 0.75

[A study of the interaction between antirheumatic preparations and proteins using the spin marker method]. Farmakol Toksikol (1975) 0.75

[Pharmacokinetics and interaction of antirheumatic preparations]. Klin Med (Mosk) (1988) 0.75

[New approaches to the basic therapy of rheumatoid arthritis]. Ter Arkh (1990) 0.75

[Study of immunology of rheumatism]. Vestn Akad Med Nauk SSSR (1967) 0.75

[Mechanism of action of antirheumatic preparations. 2. Effect of antirheumatic substances on dynamics of blood ATP levels]. Vopr Revm (1970) 0.75

[Elaboration of objective methods of clinical evaluation of new antirheumatic drugs]. Vopr Revm (1977) 0.75

[Controlled (double-blind) trial of levamisole in rheumatoid arthritis]. Ter Arkh (1980) 0.75

[Results of long-term treatment of rheumatism with resoquine]. Klin Med (Mosk) (1968) 0.75

[Laser therapy in rheumatology]. Ter Arkh (1990) 0.75

[Prospects for pulse-therapy in the treatment of rheumatoid arthritis]. Klin Med (Mosk) (1989) 0.75

[The basic therapy of rheumatoid arthritis]. Ter Arkh (1988) 0.75

[New basic preparations with prolonged action in the treatment of rheumatoid arthritis]. Ter Arkh (1987) 0.75

[Effectiveness of the treatment of juvenile rheumatoid arthritis with dimethyl sulfoxide gel]. Pediatriia (1986) 0.75

[Treatment of psoriatic arthritis with gold salts (chrysotherapy)]. Ter Arkh (1986) 0.75

[1st experience in administration of antilymphocyte serum in rheumatology]. Vopr Revm (1971) 0.75

[Herpes zoster--an unusual complication of gold therapy]. Ter Arkh (1987) 0.75

[Relapsing polychondritis]. Ter Arkh (1984) 0.75

[Current trends in pharmacotherapy of rheumatoid arthritis]. Ter Arkh (1980) 0.75